What Are the Best Vitamins to Take for Parkinson’s Disease?

No vitamin has been proven to slow or stop Parkinson’s disease on its own, and no major medical guideline currently recommends a specific vitamin regimen for it. That said, several vitamins and related nutrients have shown enough promise in clinical research to merit serious attention, especially vitamin D, certain B vitamins, and niacin-related compounds. The evidence ranges from encouraging preliminary trials to outright disappointment, and some vitamins matter less for their direct brain effects than for the way they interact with Parkinson’s medications.

Vitamin D Has the Strongest Observational Track Record

Of all the vitamins studied in connection with Parkinson’s, vitamin D has attracted the most consistent research interest. Cross-sectional studies repeatedly find that people with Parkinson’s who have lower vitamin D levels tend to have worse motor symptoms.¹ A longitudinal study tracking patients over three years found that baseline vitamin D levels were a small but statistically meaningful predictor of motor severity at the 36-month mark.²

The most compelling trial evidence comes from a Japanese randomized controlled trial in which patients received 1,200 IU of vitamin D3 daily or a placebo for 12 months. The vitamin D group showed significantly less deterioration on the Hoehn and Yahr staging scale compared to placebo. Interestingly, the benefit depended partly on genetics: patients with certain vitamin D receptor gene variants responded better than others.³ That genetic wrinkle is worth keeping in mind, because it helps explain why vitamin D supplementation doesn’t seem to help everyone equally.

A separate pilot trial tested whether vitamin D could improve balance, a common problem in Parkinson’s. The overall result was not significant, but when researchers divided participants by age, younger patients (under 67) showed a meaningful improvement in balance scores compared to older ones.⁴ These findings are far from conclusive, but the general picture is that correcting a vitamin D deficiency is a reasonable and low-risk step for anyone with Parkinson’s. Most neurologists will check a patient’s levels and recommend supplementation if they are low.

B Vitamins Play a Practical Role Because of Levodopa

The B vitamin story in Parkinson’s is less about protecting the brain directly and more about managing a side effect of the most common Parkinson’s medication: levodopa. When the body metabolizes levodopa, it produces homocysteine, a compound linked to cardiovascular problems, nerve damage, and bone loss. A meta-analysis found that homocysteine levels in people with Parkinson’s were associated with disease severity, cognitive impairment, and levodopa use.⁵ The body needs vitamins B12, B6, and folate to break down homocysteine, so supplementing these vitamins can help keep levels in check. Systematic reviews confirm that B12, B6, and folate supplementation successfully reduces the elevated homocysteine concentrations that arise from levodopa therapy.⁶

Vitamin B6 deserves special mention because it has a complicated history with Parkinson’s treatment. Decades ago, doctors noticed that B6 reduced levodopa’s effectiveness, leading to widespread advice to avoid it. That concern became largely obsolete once carbidopa and benserazide were introduced alongside levodopa in combination pills, which block the problematic interaction. Despite that, some patients still avoid B6 unnecessarily, while others supplement it without clear guidance. A 2022 study in Brain noted that Parkinson’s patients are actually at higher risk of B6 deficiency due to dietary changes, gut dysfunction, and complex drug interactions, and that deficiency can lead to peripheral neuropathy and even seizures.⁷ The bottom line: if you take a carbidopa-levodopa combination (which most Parkinson’s patients do), moderate B6 from food and a standard multivitamin is generally safe, but high-dose B6 supplements should only be taken under medical supervision.

Vitamin C Helps Levodopa Work Better

Vitamin C shows up in Parkinson’s research not so much as a brain-protective agent but as a practical booster for medication absorption. Systematic reviews of drug-nutrient interactions have found evidence that vitamin C improves levodopa absorption, enhancing clinical response and reducing the motor fluctuations that plague many patients as their disease progresses.⁸ The mechanism appears to be straightforward: vitamin C’s acidity helps levodopa absorb more completely in the gut. Some patients take a small amount of vitamin C with each levodopa dose for this reason.

By contrast, iron supplements can interfere with levodopa absorption. The same review that found vitamin C beneficial flagged ferrous sulfate supplements as potentially reducing levodopa’s effectiveness.⁸ If you need both iron supplements and levodopa, spacing them apart by a couple of hours is standard advice.

Vitamin E Was an Early Hope That Didn’t Pan Out

Vitamin E was one of the first vitamins tested in a rigorous Parkinson’s trial, back in the early 1990s. The reasoning was sound: oxidative stress contributes to the death of dopamine-producing brain cells, and vitamin E is a powerful antioxidant. The landmark DATATOP trial tested high-dose vitamin E (2,000 IU per day of tocopherol) against placebo in people with early, untreated Parkinson’s. The result was definitive: vitamin E showed no benefit whatsoever in delaying disability.⁹ That trial involved over 800 patients and remains one of the most well-powered supplement studies in Parkinson’s history. Despite ongoing interest in antioxidants generally, high-dose vitamin E is not recommended specifically for Parkinson’s.

Niacin and NAD+ Boosters Are Generating Early Excitement

Niacin, also known as vitamin B3, has drawn attention because of its role in cellular energy production and its anti-inflammatory properties. Niacin binds to a receptor called GPR109A that dampens inflammation, and research has found this receptor is upregulated in Parkinson’s patients, suggesting the body may be trying to compensate for the inflammatory damage driving the disease.¹⁰

A related compound, nicotinamide riboside (NR), is a form of vitamin B3 that boosts levels of NAD+, a molecule critical for mitochondrial energy production. The NADPARK trial, a small randomized study, found that NR successfully raised NAD+ levels, increased activity in genes related to mitochondrial and cellular cleanup functions, and decreased inflammatory markers in both blood and spinal fluid.¹¹ The researchers called NR a potential neuroprotective therapy warranting larger trials, but stressed that clinical symptom improvement has not yet been demonstrated. Larger follow-up trials are underway, so this is one to watch.

The CoQ10 Saga Shows Why Early Results Can Mislead

Coenzyme Q10 is not technically a vitamin, but it is sold as a supplement and commonly discussed alongside vitamins for Parkinson’s. Its story is a cautionary tale about getting excited too early. A 2002 trial of 80 patients found that the highest dose tested, 1,200 mg per day, appeared to slow functional decline compared to placebo, with the treated group worsening by about 5 fewer points on a standard rating scale.¹² The result generated enormous enthusiasm and prompted a much larger confirmatory trial.

That larger trial, published in 2014 with several hundred patients, found no benefit at either 1,200 mg or 2,400 mg per day. In fact, both CoQ10 groups showed a slight (non-significant) worsening trend compared to placebo.¹³ A separate Japanese pilot trial using the reduced form (ubiquinol) also found no benefit.¹⁴ CoQ10 is still widely sold for brain health, but the clinical trial evidence does not support its use for Parkinson’s.

Riboflavin Is Intriguing but Understudied

Riboflavin (vitamin B2) has biological properties that make it theoretically relevant to Parkinson’s: it helps reduce oxidative stress, supports mitochondrial function, and counters neuroinflammation.¹⁵ A small open-label study from Brazil reported striking motor improvement in 19 patients given high-dose riboflavin alongside dietary elimination of red meat, with average motor capacity rising from about 44% to 71% over six months.¹⁶

That result sounds dramatic, but it came from an uncontrolled trial with no placebo group, meaning there was no way to separate riboflavin’s effect from placebo response, the dietary changes, or natural variation in symptoms. The study was published over two decades ago and has not been replicated in a controlled trial. It remains a hypothesis rather than evidence you can act on with confidence.

Why Gut Problems in Parkinson’s Make Nutrition Harder

An underappreciated aspect of Parkinson’s nutrition is that the disease itself makes it harder to absorb nutrients properly. Gastrointestinal dysfunction is one of the hallmark non-motor symptoms of Parkinson’s, often appearing years before motor symptoms do. Problems include constipation, gastroparesis (where the stomach empties too slowly), swallowing difficulty, and reflux.¹⁷ Gastroparesis doesn’t just cause discomfort; it leads to unreliable absorption of both medications and nutrients.¹⁸

This matters practically because a person with Parkinson’s might take the right supplement at the right dose and still not absorb it well. Vitamin D levels, B12 levels, and folate levels should be checked with blood tests rather than assumed from supplement labels. If absorption is severely compromised, injectable forms of B12 or high-dose oral formulations may be necessary. Working with a dietitian who understands Parkinson’s can help sort through these issues.

Dietary Patterns Seem to Matter More Than Any Single Vitamin

While individual vitamin trials have produced mixed results, research on whole dietary patterns has been more consistently encouraging. The MIND diet, a hybrid of Mediterranean and heart-healthy eating styles that emphasizes leafy greens, berries, nuts, whole grains, and fish while limiting red meat, butter, and fried foods, has been linked to both reduced risk and slower progression of parkinsonian symptoms in older adults.¹⁹

A separate study found that higher MIND diet adherence correlated with later age of onset for Parkinson’s, with the strongest effect in women. Differences between the lowest and highest adherence groups corresponded to up to 17 years of delayed onset in the female subgroup.²⁰ These are observational findings, so they can’t prove cause and effect. But they suggest that the vitamin and nutrient combinations found naturally in a varied, plant-rich diet provide something that isolated supplements do not easily replicate.

What About Vitamin K2 and Other Emerging Compounds?

Vitamin K2 generated headlines after a study in fruit flies found it could serve as an alternative electron carrier in mitochondria, effectively rescuing cells with a genetic defect (PINK1 mutation) associated with early-onset Parkinson’s.²¹ The biology is fascinating: vitamin K2 essentially substituted for coenzyme Q10 in the mitochondrial energy chain, restoring normal energy production. But this was a fly study, and the gap between rescuing mitochondrial function in Drosophila and helping a human patient is enormous. No clinical trials of vitamin K2 for Parkinson’s have been published, making this purely speculative at this point.

Urate, a natural antioxidant and the end product of purine metabolism, has also attracted interest because higher blood urate levels have been linked to slower disease progression. A research program explored whether raising urate levels could be neuroprotective.²² While urate is not a vitamin, the connection is relevant because vitamin C can raise urate levels, adding another potential reason vitamin C might be useful alongside standard Parkinson’s treatment. However, deliberately raising urate carries its own risks, including gout and kidney stones, so this approach has not become standard.

Why Oxidative Stress Keeps Coming Up

A common thread through nearly all vitamin research in Parkinson’s is oxidative stress. The dopamine-producing neurons that die in Parkinson’s are unusually vulnerable to oxidative damage, partly because of their high energy demands and their reliance on calcium signaling.^{23 24} This biological reality is what makes antioxidant vitamins seem like logical candidates. But the failure of vitamin E in the DATATOP trial and the mixed results with CoQ10 illustrate a frustrating pattern: oxidative stress is genuinely involved in the disease, yet simply flooding the body with antioxidant supplements does not reliably reach the right cells at the right concentrations to make a clinical difference.

The research community hasn’t given up on the oxidative stress angle, but the focus has shifted toward more targeted approaches, like NAD+ boosters that support the cell’s own repair machinery rather than acting as simple free-radical scavengers.²⁵

Safety Considerations and Drug Interactions

The general safety profile of vitamins is reassuring at standard doses, but Parkinson’s patients face specific risks that healthy adults do not. A review of vitamin benefits in Parkinson’s noted that while proper supplementation can improve symptoms, the safety of regular vitamin use still needs to be highlighted.²⁶ A few specific interactions are worth knowing about:

• Iron and levodopa: Iron supplements reduce levodopa absorption and should be taken at least two hours apart from medication doses.
• High-dose B6 without carbidopa: If you take levodopa without a decarboxylase inhibitor (rare now, but it happens with some compounded formulations), high-dose B6 can reduce the drug’s effectiveness.
• High-protein meals: While not a vitamin issue per se, high-protein meals compete with levodopa for absorption in the gut. Protein redistribution diets, where most protein is eaten at dinner rather than throughout the day, can improve medication response.⁶
• High-dose vitamin E: At the 2,000 IU doses tested in the DATATOP trial, vitamin E showed no benefit and can increase bleeding risk in people on blood thinners.

These interactions reinforce the importance of discussing any new supplement with your neurologist or pharmacist before starting it. The risk of a harmful interaction is generally low, but the consequences of interfering with levodopa absorption can be significant in daily functioning.

When Genetic Subtypes Might Matter

You might wonder whether different genetic forms of Parkinson’s respond differently to vitamin supplementation. A study comparing patients with mutations in GBA or LRRK2 genes (two of the most common genetic risk factors) against those with idiopathic Parkinson’s measured various biochemical markers, including vitamin D and uric acid levels. The result was surprising in its simplicity: no significant differences were found among the groups.²⁷ This doesn’t mean genetics are irrelevant to vitamin response, as the vitamin D receptor finding from the Japanese trial showed. But it does mean that known genetic subtypes of Parkinson’s don’t appear to create dramatically different nutritional profiles, at least based on current evidence.

The Supplement Landscape Among Actual Patients

Despite the limited evidence, supplement use among people with Parkinson’s is widespread. A 2025 survey of patients in Lithuania found that many regularly used nutritional supplements alongside their prescribed medications, including vitamin D, B vitamins, magnesium, and omega-3 fatty acids. The authors noted that while several popular supplements had been investigated for potential neuroprotective benefits, the body of research remains limited in supporting any of them for improving Parkinson’s symptoms or slowing progression.²⁸

That gap between what patients are taking and what the research actually supports is a common pattern in chronic neurological diseases. People understandably want to do everything possible, and vitamins feel like a low-risk option. For the most part they are, but the real danger isn’t toxicity. It is the opportunity cost of spending money and cognitive energy on supplements that have no proven effect while potentially neglecting evidence-based interventions like exercise, medication timing optimization, and dietary pattern changes that have stronger research behind them.